Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Califf's Priorities Feature Short- And Long-Term Goals Despite Potentially Brief Tenure

This article was originally published in The Tan Sheet

Executive Summary

Newly confirmed FDA Commissioner Robert Califf should not assume he will be leaving once a new president arrives, a Republican-appointed predecessor says. Industry trade groups ask Califf to make supplement industry regulation an early priority.

You may also be interested in...



Drug Pricing Activity At US FDA May Be Unique To Gottlieb Tenure

Steven Grossman argues that the former commissioner possessed the credentials to be out front on the pricing issue, unlike other recent FDA commissioners and the current holder of the office.

Gottlieb Advances, But FDA's Future Seems Increasingly Partisan

Senate committee votes to send the FDA Commissioner nominee to the Senate floor, but with only two Democratic votes.

FDA's Commissioner Fish Story Continues

US FDA met with a group concerned about seafood consumption advice for pregnant and nursing women; could it satisfy Sen. Murkowski and avoid a hold on Scott Gottlieb's nomination?

Related Content

Topics

UsernamePublicRestriction

Register

PS108188

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel